drug

Perphenazine

Phase 1: Perphenazineperphenazine
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Janssen, L.P. - Investigator Initiated Studies Program
11 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

11
Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)
NCT03510325Phase 3Completed
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
NCT02431702Phase 3Completed
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
NCT02600741—Completed
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
NCT02307396Phase 4Completed
Lurasidone Effects on Tissue Glutamate in Schizophrenia
NCT02199743Phase 4Completed
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
NCT01157351Phase 4Completed
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
NCT00737256Phase 2Unknown
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
NCT01193166Phase 4Withdrawn
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
NCT00802100Phase 4Completed
CATIE- Schizophrenia Trial
NCT00014001Phase 4Completed

KOLs & investigators

9
Stefan Leucht, ProfessorKOL score 87
Jeffrey A. Lieberman, MDKOL score 9
Helge Frieling, Prof., MDKOL score 5
T. Scott Stroup, MD, MPHKOL score 5
Carol A. Tamminga, M.D.KOL score 5
Joseph P. McEvoy, MDKOL score 4
Thomas P Beresford, MD
Marvin Swartz, MD
Markus Dold, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Janssen, L.P. - Investigator Initiated Studies Program
company
trial
Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)
PHASE3
trial
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
PHASE3
trial
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
trial
Pharmacovigilance in Gerontopsychiatric Patients
PHASE3
trial
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
PHASE4
trial
indication
Schizophrenia
indication
Depression
indication
Psychosomatic Disorders
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
KOL
Stefan Leucht, Professor
KOL score 87
person
Jeffrey A. Lieberman, MD
KOL score 9
person
Helge Frieling, Prof., MD
KOL score 5
person
T. Scott Stroup, MD, MPH
KOL score 5
person